Search

everythinglearnresearchcommunity

for

Search:↓

Restolin Hair Supplement may help hair growth but lacks FDA approval and clinical trial evidence.

Hemp shows promise for skincare and hair care due to its therapeutic properties, but standardization and clinical evidence are needed.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Current evidence is insufficient to fully endorse regenerative therapies for hair loss.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Pediatric androgenetic alopecia is underrecognized, and clinical evaluation is crucial for diagnosis, with potential treatments including minoxidil and finasteride.

The document concludes that the first book on mesotherapy lacks convincing evidence, the second book is good for beginners in facial rejuvenation, and the third book is valuable for understanding complications in skin surgery.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

It's unclear if cell-based therapies from lipoaspirate devices improve clinical outcomes due to inconsistent data.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

There is not enough evidence to recommend multivitamin-mineral supplements and herbal treatments for alopecia areata.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

Mesotherapy for hair loss lacks strong evidence and clear guidelines for its effectiveness and product use.

The authors agree that biotin may help certain hair disorders but lacks evidence for use in healthy people and call for more research.

Effective acne treatment varies by type, with topical and oral medications showing strong evidence, and patient education and support are crucial.

Laser therapy shows promise for hair loss but lacks strong evidence due to limited studies.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Regenerative aesthetic medicine aims to restore tissue function, but needs more consistent evidence and standardized practices.

Turmeric may improve knee osteoarthritis, depression, and metabolic syndrome, but evidence is weak.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Exosomes show promise in dermatology but need more research and FDA approval for clinical use.

Exosome therapy for hair loss shows promise but needs standardized methods and safety checks for clinical use.

Many popular skincare products claim to prevent aging but lack strong evidence to prove their effectiveness and safety.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

The document concludes that products like PRP and PRF show promise for tissue healing, but evidence of their effectiveness is inconsistent.

Baldness may be linked to heart disease, but the evidence isn't strong enough to consider it a major risk factor.